

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Adrenergic Receptor ↓ ↑ | α-adrenergic receptor ↓ ↑ | β-adrenergic receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivabradine HCl | ✔ | 98% | |||||||||||||||||
| Maprotiline HCl | ✔ | 98% | |||||||||||||||||
| Cisatracurium besylate | ✔ | 96% | |||||||||||||||||
| Yohimbine HCI | ✔ | 99+% | |||||||||||||||||
| BMY 7378 |
++
α2C-adrenoceptor, pKi: 6.54 α1D-adrenoceptor, pKi: 5.1 |
+
β1-adrenoceptor, pIC50: 5.1 |
97% | ||||||||||||||||
| Asenapine maleate |
++++
α2B-adrenergic receptor, pKi: 8.9 α2A-adrenergic receptor, pKi: 8.9 |
97% | |||||||||||||||||
| Piribedil |
++
adrenoceptor α2C, pKi: 7.2 adrenoceptor α2A, pKi: 7.1 |
98% | |||||||||||||||||
| Prazosin HCl | ✔ | 95% | |||||||||||||||||
| Silodosin | ✔ | 98% | |||||||||||||||||
| Phenoxybenzamine HCl | ✔ | 98% | |||||||||||||||||
| Labetalol HCl | ✔ | 98+% | |||||||||||||||||
| Naftopidil |
+++
α1A-adrenergic receptor, Ki: 3.7 nM α1D-adrenergic receptor, Ki: 20 nM |
98% | |||||||||||||||||
| Naftopidil 2HCl |
+
α1-adrenergic receptor, IC50: 0.2 μM |
99% | |||||||||||||||||
| Alfuzosin HCl | ✔ | 98% | |||||||||||||||||
| Terazosin HCl | ✔ | 99% | |||||||||||||||||
| Atipamezole | ✔ | 95% | |||||||||||||||||
| Phentolamine methanesulfonate salt | ✔ | 99% | |||||||||||||||||
| Carvedilol | ✔ | 99% | |||||||||||||||||
| Doxazosin mesylate | ✔ | 99% | |||||||||||||||||
| Tolazoline HCl | ✔ | 98% | |||||||||||||||||
| Esmolol HCl | ✔ | 95% | |||||||||||||||||
| Propranolol HCl |
++
β-adrenergic receptor, IC50: 12 nM |
99% | |||||||||||||||||
| Zenidolol HCl |
++++
β1-adrenergic receptor, Ki: 611nM β2-adrenergic receptor, Ki: 0.7nM |
98% | |||||||||||||||||
| Acebutolol HCl | ✔ | 97+% | |||||||||||||||||
| Carteolol HCl | ✔ | 98+% | |||||||||||||||||
| Betaxolol | ✔ | 99% | |||||||||||||||||
| Betaxolol HCl |
+
β1-adrenergic receptor, IC50: 6 μM |
97% | |||||||||||||||||
| Bisoprolol | ✔ | 97% | |||||||||||||||||
| Sotalol HCl | ✔ | 95+% | |||||||||||||||||
| Nebivolol HCl |
+++
β1-adrenoceptor, IC50: 0.8 nM |
99% | |||||||||||||||||
| Metoprolol | ✔ | 98+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Naftopidil is a selective α1-adrenergic receptor antagonist or α receptor inhibitor with Ki of 58.3 nM. In vivo, forty minutes after the intravenous administration of naftopidil, the selectivity index was 3.76, naftopidil selectively inhibited the phenylephrine-induced increase in prostatic pressure[3]. In vitro, the concentrations causing 50% inhibition (IC50) of cancer cell growth were 22.2 ± 4.0 microM in androgen-sensitive LNCaP cells and 33.2 ± 1.1 microM in androgen-insensitive PC-3 cells. In vivo, oral administration of naftopidil to nude mice inhibited the growth of PC-3 tumors as compared to vehicle-treated controls[4]. Moreover, naftopidil induced apoptosis in all the investigated malignant mesothelioma cells[5]. |
| Concentration | Treated Time | Description | References | |
| IGROV1-R10 cells | 50 µM | 48 h | Naftopidil inhibited IGROV1-R10 cell proliferation and increased the expression of BH3-only proteins Bim, Puma, and Noxa | Cell Death Dis. 2020 May 18;11(5):380. |
| SKOV3 cells | 50 µM | 48 h | Naftopidil inhibited SKOV3 cell proliferation and increased the expression of BH3-only proteins Bim, Puma, and Noxa | Cell Death Dis. 2020 May 18;11(5):380. |
| LL97A | 0-80 µmol/L | 48 h | Naftopidil decreased the proliferation of LL97A cells in a dose-dependent manner | J Cell Mol Med. 2019 May;23(5):3563-3571. |
| TIG-1-20 | 0-80 µmol/L | 48 h | Naftopidil decreased the proliferation of TIG-1-20 cells in a dose-dependent manner | J Cell Mol Med. 2019 May;23(5):3563-3571. |
| WI-38 | 0-80 µmol/L | 48 h | Naftopidil decreased the proliferation of WI-38 cells in a dose-dependent manner | J Cell Mol Med. 2019 May;23(5):3563-3571. |
| KGN cells | 20 µM | 24 h | To verify the regulatory effects of (R)-NAF and (S)-NAF on UGT2B15 expression, results showed they upregulated UGT2B15 expression and reduced DHT accumulation. | J Ovarian Res. 2025 Jan 24;18(1):13. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6J mice | Bleomycin-induced lung fibrosis model | Oral | 30 mg/kg | 5 days a week for 28 days | Naftopidil attenuated bleomycin-induced lung fibrosis, reduced collagen deposition and the number of α-SMA-positive myofibroblasts, and decreased serum surfactant protein-D levels | J Cell Mol Med. 2019 May;23(5):3563-3571. |
| C57BL/6J mice | PCOS mouse model | Oral gavage | 10 mg/mL | Once daily for 6 weeks | To evaluate the ameliorative effects of (R)-NAF and (S)-NAF on PCOS symptoms in mice, results showed they upregulated UGT2Bs expression, reduced androgen accumulation, and improved ovarian morphology and menstrual cycles. | J Ovarian Res. 2025 Jan 24;18(1):13. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01203371 | Hyperplasia | Phase 3 | Unknown | January 2012 | Brazil ... 展开 >> Hospital das Clínicas da Faculdade de Medicina da USP Not yet recruiting São Paulo, Brazil, 05403-010 Contact: Geraldo C Freire, PhD 55 11 3069-8082 Contact: Camila C Marin 55 11 3069-8082 camila.marin@ig.com.br Principal Investigator: Geraldo C Freire, PhD 收起 << |
| NCT02034604 | Neurogenic Lower Urinary Tract... 展开 >> Dysfunction 收起 << | Phase 4 | Unknown | April 2015 | Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 130-710 Contact: Kyu-Sung Lee, M.D., Ph.D. 82-2-3410-3554 ksleedr@skku.edu Contact: Hyun Wook You, M.D. 82-2-3410-1268 khdoct29@gmail.com Principal Investigator: Kyu-Sung Lee, Ph.D, M.D. 收起 << |
| NCT01922375 | Lower Urinary Tract Symptoms A... 展开 >>ssociated With Benign Prostatic Hyperplasia 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Chonnam national university hospital Gwangju, Korea, Republic of 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.55mL 0.51mL 0.25mL |
12.74mL 2.55mL 1.27mL |
25.48mL 5.10mL 2.55mL |
|
| CAS号 | 57149-07-2 |
| 分子式 | C24H28N2O3 |
| 分子量 | 392.49 |
| SMILES Code | OC(COC1=C2C=CC=CC2=CC=C1)CN3CCN(C4=CC=CC=C4OC)CC3 |
| MDL No. | MFCD00242741 |
| 别名 | KT-611; BM-15275; Flivas |
| 运输 | 蓝冰 |
| InChI Key | HRRBJVNMSRJFHQ-UHFFFAOYSA-N |
| Pubchem ID | 4418 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature |
| 溶解方案 |
DMSO: 35 mg/mL(89.17 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1